These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8922941)

  • 1. Combined heart failure treatment with ACE inhibition and AT1-receptor blockade.
    Willenheimer R; Cline C; Erhardt L
    Eur Heart J; 1996 Nov; 17(11):1768-9. PubMed ID: 8922941
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
    Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
    [No Abstract]   [Full Text] [Related]  

  • 5. Losartan versus captopril in elderly patients with heart failure.
    Fournier A; Achard JM; Fernandez LA
    Lancet; 1997 May; 349(9063):1473-4; author reply 1475. PubMed ID: 9164336
    [No Abstract]   [Full Text] [Related]  

  • 6. Losartan versus captopril in elderly patients with heart failure.
    Sechi LA; Catena C; Bartoli E
    Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337
    [No Abstract]   [Full Text] [Related]  

  • 7. Losartan versus captopril in elderly patients with heart failure.
    Ball SG
    Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338
    [No Abstract]   [Full Text] [Related]  

  • 8. Losartan versus captopril in elderly patients with heart failure.
    Jensen BV; Nielsen SL
    Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
    Pitt B; Chang P; Timmermans PB
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiproteinuric effect of Losartan in patients with chronic renal diseases.
    Zoccali C; Valvo E; Russo D; Panichi V; Zuccala' A
    Nephrol Dial Transplant; 1997 Jan; 12(1):234-5. PubMed ID: 9027813
    [No Abstract]   [Full Text] [Related]  

  • 13. Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure.
    Rush JE; Rajfer SI
    J Hypertens Suppl; 1993 Apr; 11(3):S69-71. PubMed ID: 8315523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
    Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan in post-transplant erythrocytosis.
    Conlon PJ; Smith SR; Butterly DW; Brennan DC
    Nephrol Dial Transplant; 1996 Dec; 11(12):2524-5. PubMed ID: 9017645
    [No Abstract]   [Full Text] [Related]  

  • 16. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
    Ellis ML; Patterson JH
    Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
    Elicio N; Bertolini S; Garbarini R; Nardiello G; Elicio A; Aimale V
    Artif Organs; 1997 Apr; 21(4):334-5. PubMed ID: 9096809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.
    Hope S; Brecher P; Chobanian AV
    Am J Hypertens; 1999 Jan; 12(1 Pt 1):28-34. PubMed ID: 10075381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
    Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
    Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists in chronic heart failure: where do they fit?
    Houghton AR
    Drugs; 2002; 62(10):1433-40. PubMed ID: 12093312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.